Spherix Global Insights

July 16, 2021

Cleveland Clinic and Mount Sinai say they will not administer controversial Alzheimer’s drug

From: Daily Mail

By: Mansur Shaheen


DailyMail.com launches in America


A survey of neurologists by Spherix Global Insights found that neurologists only believe the drug is adequate for use in one-in-seven Alzheimer’s patients…(read more)